Exonate Limited raised £1m in Angel Investment to develop life-changing eye drops
Finance enabled this biotechnology company to reach scientific milestones and receive awards, opening up more rounds of finance to further grow the business.
Exonate business fact-file
|Types of funding||Angel Investment|
We required working capital to hire key staff and undertake a development programme, which included laboratory space and equipment.
£1 million of Angel Investment
Securing finance has allowed the business to grow and to move the development of a potentially life changing drug closer to the clinic.
Exonate's Journey to Finance
- Exonate is a biotechnology company that develops drugs for the treatment of diseases of the back of the eye.
- Our goal is to develop eye drops to replace injections directly into the eye; eye drops would be the holy grail.
- We required finance in order to hire key scientists, as well as rent laboratory space from the University of Nottingham and to buy laboratory equipment.
- I have had personal experience fund raising and I was confident that Exonate was in an interesting space and would be able to get funding.
- Initially we decided to seek £250,000 to carry out small experiments but we were over subscribed and managed to secure £500,000 from an Angel syndicate and the University of Nottingham. This allowed the company to create data which attracted further funds.
Exonate's Top Tips
Talk to similar businesses to find out what worked for them and ask for introductions to their funders where appropriate.
Manage your investor
Angel investors are investing their own funds and therefore wish to remain in contact with the management team and monitor progress. This is understandable and needs to be managed carefully.
Legal takes time
The legal documentation was in depth and took the majority of time to negotiate.
The best bits about Angel Investment
- We received funds from individuals and organisations with real expertise in the area of biotechnology
- They have made introductions to potential partners and future investors
- We have received advice around the direction of our development
LivingLens used Venture Capital investment to raise £2.5m to grow its team and expand into new markets.
From a Start Up Loan to a £900,000 Crowdunding round, Cornerstone is growing and has used finance to do it.
A £10m Expansion Capital investment helped an established Chemical manufacturer build a major new plant.